State Of Wyoming Affimed N.V. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $608 - $1,302	268 Added 156.73%	439 $1,000
Q1 2022 May 13, 2022	BUY	$3.69 - $5.65 $597 - $915	162 Added 1800.0%	171 $1,000
Q3 2021 Feb 11, 2022	SELL	$5.54 - $7.51 $27 - $37	-5 Reduced 35.71%	9 $0
Q2 2021 Feb 11, 2022	BUY	$7.78 - $11.4 $108 - $159	14 New	14 $0

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.